NKGN NKGen Biotech Accounting Capitalization

NKGen Biotech, Inc. (NKGN) focuses on developing innovative NK-cell based therapies to combat Alzheimer's disease and is currently in the clinical trial stage. The cultivation process of immune units is automated via robotics, which eliminates human error and facilitates scaling. This chart reflects the current share price, fixed at -0.12, complementing data regarding the company's own cGMP sterile facility in California for the production of biologics.

NKGN NKGen Biotech Book Capitalization (02/21/2024 - 03/15/2025)

Metric breakdowns and analytics for NKGen Biotech (NKGN)

- price and consensus price forecast:
Price Rate Chart NKGen Biotech Corp|NKGN - Price Target Chart
- market capitalization data:
Market Capitalization NKGen Biotech Inc|NKGN - Total Company Value
- book capitalization data:
Equity per Share NKGen Biotech|NKGN - Book Capitalization|Market-to-Book Ratio nkgenbiotech.com|NKGN - Cumulative Company Assets
- debt and liquidity data:
Total Debt to Capital NKGen Biotech, Inc.|NKGN - Long-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital NKGen Biotech Inc|NKGN - Company Debts|Debts to Book Value NKGen Biotech Inc|NKGN - Company Long-Term Debt|Company Short-Term Indebtedness NKGen Biotech
Summary company analysis:NKGen Biotech Corp - NKGN

This metric serves as a filter during asset stress testing, allowing for the exclusion of market volatility to assess the intrinsic value of the business. Book capitalization reflects the difference between all assets and liabilities, while the book equity chart for NKGen Biotech, Inc. (NKGN) demonstrates a financial base constrained by the labor intensity of individual cell cultivation, which hinders the rapid scaling of capital through assembly-line production.

Main competitors

BIIB: Book Value of Business|Company Book Value Neurocrine Biosciences|RGC (regencellbioscience.com) - Accounting Capitalization|Company Book Value Axsome Therapeutics, Inc. (AXSM)|Accounting Capitalization ACADIA Pharma|Xenon Pharmaceuticals Inc - Book Capitalization|Total Stockholders' Equity Viking Therapeutics Corp VKTX|Company Net Assets SUPN (Supernus Pharmaceuticals)|catalystpharma.com - Book Capitalization|Company Book Value Denali Therapeutics Inc. (DNLI)|HRMY: Accounting Value of Company|Company Book Value BHVN|AMLX (Amylyx Corp) - Total Stockholders' Equity|Company Book Value Trevi Therapeutics (TRVI)|Accounting Capitalization PRAX|Company Book Value AVXL|Book Capitalization CeriBell Inc (CBLL)|PRTA (prothena.com) - Book Capitalization|Book Value of Business Alector Inc. ALEC|ANNX (Annexon, Inc.) - Book Capitalization|OMER: Total Stockholders' Equity|Company Book Value Neurogene|Accounting Capitalization AC Immune S.A.|VYGR - Company Net Assets|Accounting Value of Company Neumora Corp|Book Capitalization Scilex Holding Company (SCLX)|Company Book Value tevogen.com (TVGN)|Book Capitalization ACOG|cogrx.com - Book Valuation of Business|IKT (Inhibikase) - Company Book Value|Cassava Pharma (SAVA) - Total Stockholders' Equity|ASRT - Company Net Assets|Coya Therapeutics (COYA) - Total Net Assets|Book Capitalization VTGN (VistaGen Therapeutics, Inc.)|Total Stockholders' Equity Ovid Rx|Book Capitalization ABOS (Acumen Pharma)|Company Net Assets CervoMed Corporation (CRVO)|Book Capitalization Alterity Therapeutics Limited|CLNN - Accounting Value of Company|Company Net Assets PepGen Corp (PEPG)|JUNS - Accounting Value of Company|Relmada - Book Capitalization|ANVS (Annovis Bio Corporation) - Book Valuation of Business|Company Book Value Grace Therapeutics Inc (GRCE)|Accounting Capitalization fireflyneuro.com|Book Capitalization KLTO (Klotho Neurosciences Inc)|Company Net Assets neurosense-tx.com NRSN|Company Net Assets RVPH|MetaVia Inc. - Book Valuation of Business|NeurAxis, Inc. (NRXS) - Company Book Value|HSDT: Accounting Capitalization|PASG: Company Book Value|Neuphoria Therapeutics (NEUP) - Book Capitalization|Minerva Neurosciences Corp - Book Capitalization|Book Value of Business ATHA|Company Book Value Addex Therapeutics ADXN|Accounting Capitalization ALZN (alzamend.com)|CYCN - Company Book Value|Accounting Capitalization Protagenic Therapeutics Inc. PTIX|KTTA (Pasithea) - Book Capitalization|Cortigent, Inc. (CRGT) - Total Stockholders' Equity|ATXI: Company Net Assets|BCLI (brainstorm-cell.com) - Book Capitalization|CARA - Company Book Value|Accounting Value of Company CHRO|Eliem Therapeutics - Company Book Value|Total Stockholders' Equity ITCI (intracellulartherapies.com)|LBPH - Company Book Value|marinuspharma.com - Accounting Capitalization|NeuroBo Pharmaceuticals, Inc. - Company Book Value|SAGE - Book Capitalization|Book Capitalization SNPX (Neurotrope)|Trevena Inc (TRVN) - Book Value of Business|Book Capitalization VIGL (Vigil Neuroscience Inc.)|Total Stockholders' Equity WENA|Company Book Value Cerevel Therapeutics, Inc. CERE